MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
- DOI
- 10.1186/s13058-015-0515-1
- Published
- 2015 Jan 30
- Container
- Breast cancer research : BCR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13058-015-0515-1,
title = {MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.},
author = {Vilquin P and Donini CF and Villedieu M and Grisard E and Corbo L and Bachelot T and Vendrell JA and Cohen PA},
year = {2015},
journal = {Breast cancer research : BCR},
doi = {10.1186/s13058-015-0515-1},
url = {https://doi.org/10.1186/s13058-015-0515-1}
}RIS
TY - JOUR TI - MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. AU - Vilquin P AU - Donini CF AU - Villedieu M AU - Grisard E AU - Corbo L AU - Bachelot T AU - Vendrell JA AU - Cohen PA PY - 2015 JO - Breast cancer research : BCR DO - 10.1186/s13058-015-0515-1 UR - https://doi.org/10.1186/s13058-015-0515-1 ER -
APA
P, V., CF, D., M, V., E, G., L, C., T, B., JA, V., & PA, C. (2015). MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.. Breast cancer research : BCR. https://doi.org/10.1186/s13058-015-0515-1
Source records
- pubmed · retrieved 2026-09-26T19:49:08.368Z